Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.
Press releases published on September 23, 2025
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com, a financial news and content platform, reports that Coeptis Therapeutics (NASDAQ: COEP) is pioneering a dual-track model designed to sustain innovation while reducing reliance on …
Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company will be presenting an update on its application for Orphan Drug status to the U.S. Food and Drug Administration (FDA) for …
EagleNXT Reseller Network in Asia Pacific Renew Agreements
Confidence in EagleNXT, Increased Sales and Growing Demand Spurs Company’s Increasing Regional Success WICHITA, Kan., Sept. 23, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading …
BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the …
Rezolve Ai Founder and CEO Daniel M. Wagner to Speak at the 3rd Annual Roth AI Summit 2025
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, announced that its Founder and Chief Executive Officer, Daniel M. Wagner, will participate in a virtual …
Genius Group Announces 25% Increase in Revenue on proforma basis, 57% Decrease in Net Loss per Share in First Half of 2025
Total assets increased 20% to $121.3 million SINGAPORE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced its financial …
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
SEATTLE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced its recognition by both Endpoints News and Fierce Biotech as one …
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis
Pediatric dosing expected to begin in Q4 2025 Pivotal cohort expected to begin enrolling in Q1 2026 BLA submission anticipated in early 2028 Part A results demonstrated efficacy and safety; ATSN-201 on track to be first gene therapy and one-time treatment …
ZenaTech Closes Tenth Acquisition of A&J Land Surveyor Inc., Expanding Drone as a Service (DaaS) to Florida’s Aviation, Utility, and Infrastructure Markets
VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will host a …
Altimmune to Participate in Two Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the …
reAlpha Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
DUBLIN, Ohio, Sept. 23, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced that on September 22, 2025, it received a letter from the Listing Qualifications …
ZenaTech cierra su décima adquisición de A&J Inc., expandiendo Drone como Servicio (DaaS) a los mercados de aviación, servicios públicos e infraestructura de Florida
VANCOUVER, Columbia Británica, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drone como …
Crane NXT Expects High Single Digit Revenue Growth in its U.S. Currency Business in 2026
WALTHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT) ("Crane NXT" or the "Company"), a premier industrial technology company, today announced it expects its U.S. Currency business to grow in the high-single-digits in 2026 based on …
Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22
Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22 First disclosure of a novel mechanism of action for the degradation of TEAD by selectively inducing its …
Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA
SUNRISE, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announces that its abbreviated new drug …
Symbotic and Nyobolt Announce New Performance-Improving Power Technology for SymBot™ Autonomous Mobile Robots
Enhanced battery technology provides ultra-fast charging with six times more energy capacity than existing solution Transformational hardware can be retrofitted into existing systems at customer facilities WILMINGTON, Mass. and CAMBRIDGE, United Kingdom, …
Calian Launches Canada’s First Defence Innovation Orchestrator to Scale Small to Mid-Sized Enterprise
OTTAWA, Ontario, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a trusted provider of mission-critical solutions for defence, space, healthcare and other critical infrastructure sectors, announced today the launch of Calian Ventures, a …
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
Seasoned AI-Biotech veteran strengthens the company’s leadership in AI and mitochondrial medicine Co-Inventor of AI platform boosts company’s momentum in advancing late-stage assets to commercialization BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- BPGbio Inc …
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transplant for the treatment of hematological …